ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Adiponectin, an adipocytokine in inverse proportion to the body mass index that enhances the burning of fatty acids and the anti-inflammatory effect and improves IR and the pathological condition of NAFLD, can be used as an effective therapy against dyslipidemias and IR that accompanies obesity or NAFLD [18].